US Stock MarketDetailed Quotes

Zymeworks (ZYME)

Watchlist
  • 27.800
  • +0.600+2.21%
Close Apr 17 16:00 ET
  • 27.800
  • 0.0000.00%
Post 20:01 ET
2.07BMarket Cap-25.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zymeworks (ZYME) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
38.87%105.97M
-91.90%2.52M
72.59%27.61M
153.21%48.73M
170.29%27.11M
0.38%76.3M
83.33%31.03M
-3.07%16M
174.82%19.24M
-71.81%10.03M
Operating revenue
38.87%105.97M
-91.90%2.52M
72.59%27.61M
153.21%48.73M
170.29%27.11M
0.38%76.3M
83.33%31.03M
-3.07%16M
174.82%19.24M
-71.81%10.03M
Cost of revenue
Gross profit
Operating expense
1.21%198.5M
-12.44%46.64M
-1.14%49.68M
10.00%49.35M
10.23%52.74M
-8.36%196.12M
32.09%53.26M
0.96%50.25M
-26.59%44.86M
-23.89%47.84M
Selling and administrative expenses
0.00%61.5M
-4.94%15.4M
1.44%14.1M
-5.10%14.9M
7.59%17M
-12.64%61.5M
9.46%16.2M
-18.24%13.9M
-27.68%15.7M
-6.77%15.8M
-General and administrative expense
0.00%61.5M
-4.94%15.4M
1.44%14.1M
-5.10%14.9M
7.59%17M
-12.64%61.5M
9.46%16.2M
-18.24%13.9M
-27.68%15.7M
-6.77%15.8M
Research and development costs
1.77%137M
-15.72%31.24M
-2.13%35.58M
18.13%34.45M
11.53%35.74M
-6.27%134.62M
45.21%37.06M
10.92%36.35M
-26.00%29.16M
-30.21%32.04M
Operating profit
22.77%-92.54M
-98.45%-44.12M
35.59%-22.06M
97.57%-623K
32.22%-25.63M
13.18%-119.82M
4.98%-22.23M
-2.96%-34.25M
52.66%-25.62M
-38.60%-37.81M
Net non-operating interest income expense
-33.03%13.35M
-27.12%2.98M
-26.25%3.53M
-33.53%3.43M
-42.16%3.42M
1.20%19.94M
-19.15%4.08M
-4.80%4.79M
6.82%5.15M
23.20%5.92M
Non-operating interest income
-33.03%13.35M
-27.12%2.98M
-26.25%3.53M
-33.53%3.43M
-42.16%3.42M
1.20%19.94M
-19.15%4.08M
-4.80%4.79M
6.82%5.15M
23.20%5.92M
Other net income (expense)
96.66%-559K
-187.79%-302K
254.41%315K
96.38%-621K
-83.88%49K
-1,771.25%-16.73M
141.35%344K
-132.18%-204K
-8,116.75%-17.17M
162.42%304K
Gain on sale of security
-178.61%-610K
-147.57%-284K
273.05%289K
-1,104.92%-613K
-100.70%-2K
165.49%776K
207.76%597K
-163.26%-167K
113.90%61K
162.50%285K
Special income (charges)
--0
--0
--0
--0
----
---17.29M
--0
--0
---17.29M
----
-Less:Impairment of capital assets
--0
--0
--0
--0
----
--17.29M
--0
--0
--17.29M
----
Other non- operating income (expenses)
123.39%51K
92.89%-18K
170.27%26K
-115.09%-8K
168.42%51K
-174.91%-218K
8.99%-253K
-110.00%-37K
-76.96%53K
161.29%19K
Income before tax
31.61%-79.75M
-133.15%-41.48M
38.34%-18.27M
105.66%2.13M
29.89%-22.14M
2.21%-116.61M
7.36%-17.79M
-7.42%-29.62M
24.00%-37.62M
-37.52%-31.58M
Income tax
-77.38%1.38M
-104.72%-270K
491.15%1.34M
-373.53%-186K
561.33%496K
1,171.13%6.08M
221.03%5.72M
-79.64%226K
-95.89%68K
-94.60%75K
Net income
33.88%-81.13M
-75.31%-41.21M
34.33%-19.6M
106.15%2.32M
28.49%-22.64M
-3.39%-122.7M
-62.31%-23.51M
-4.05%-29.85M
26.33%-37.69M
-29.98%-31.65M
Net income continuous Operations
33.88%-81.13M
-75.31%-41.21M
34.33%-19.6M
106.15%2.32M
28.49%-22.64M
-3.39%-122.7M
-62.31%-23.51M
-4.05%-29.85M
26.33%-37.69M
-29.98%-31.65M
Minority interest income
Net income attributable to the parent company
33.88%-81.13M
-75.31%-41.21M
34.33%-19.6M
106.15%2.32M
28.49%-22.64M
-3.39%-122.7M
-62.31%-23.51M
-4.05%-29.85M
26.33%-37.69M
-29.98%-31.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
33.88%-81.13M
-75.31%-41.21M
34.33%-19.6M
106.15%2.32M
28.49%-22.64M
-3.39%-122.7M
-62.31%-23.51M
-4.05%-29.85M
26.33%-37.69M
-29.98%-31.65M
Basic earnings per share
33.33%-1.08
-77.42%-0.55
33.33%-0.26
106.12%0.03
28.57%-0.3
5.81%-1.62
-63.16%-0.31
4.88%-0.39
35.53%-0.49
-16.67%-0.42
Diluted earnings per share
33.33%-1.08
-77.42%-0.55
33.33%-0.26
106.12%0.03
28.57%-0.3
5.81%-1.62
-63.16%-0.31
4.88%-0.39
35.53%-0.49
-13.51%-0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 38.87%105.97M-91.90%2.52M72.59%27.61M153.21%48.73M170.29%27.11M0.38%76.3M83.33%31.03M-3.07%16M174.82%19.24M-71.81%10.03M
Operating revenue 38.87%105.97M-91.90%2.52M72.59%27.61M153.21%48.73M170.29%27.11M0.38%76.3M83.33%31.03M-3.07%16M174.82%19.24M-71.81%10.03M
Cost of revenue
Gross profit
Operating expense 1.21%198.5M-12.44%46.64M-1.14%49.68M10.00%49.35M10.23%52.74M-8.36%196.12M32.09%53.26M0.96%50.25M-26.59%44.86M-23.89%47.84M
Selling and administrative expenses 0.00%61.5M-4.94%15.4M1.44%14.1M-5.10%14.9M7.59%17M-12.64%61.5M9.46%16.2M-18.24%13.9M-27.68%15.7M-6.77%15.8M
-General and administrative expense 0.00%61.5M-4.94%15.4M1.44%14.1M-5.10%14.9M7.59%17M-12.64%61.5M9.46%16.2M-18.24%13.9M-27.68%15.7M-6.77%15.8M
Research and development costs 1.77%137M-15.72%31.24M-2.13%35.58M18.13%34.45M11.53%35.74M-6.27%134.62M45.21%37.06M10.92%36.35M-26.00%29.16M-30.21%32.04M
Operating profit 22.77%-92.54M-98.45%-44.12M35.59%-22.06M97.57%-623K32.22%-25.63M13.18%-119.82M4.98%-22.23M-2.96%-34.25M52.66%-25.62M-38.60%-37.81M
Net non-operating interest income expense -33.03%13.35M-27.12%2.98M-26.25%3.53M-33.53%3.43M-42.16%3.42M1.20%19.94M-19.15%4.08M-4.80%4.79M6.82%5.15M23.20%5.92M
Non-operating interest income -33.03%13.35M-27.12%2.98M-26.25%3.53M-33.53%3.43M-42.16%3.42M1.20%19.94M-19.15%4.08M-4.80%4.79M6.82%5.15M23.20%5.92M
Other net income (expense) 96.66%-559K-187.79%-302K254.41%315K96.38%-621K-83.88%49K-1,771.25%-16.73M141.35%344K-132.18%-204K-8,116.75%-17.17M162.42%304K
Gain on sale of security -178.61%-610K-147.57%-284K273.05%289K-1,104.92%-613K-100.70%-2K165.49%776K207.76%597K-163.26%-167K113.90%61K162.50%285K
Special income (charges) --0--0--0--0-------17.29M--0--0---17.29M----
-Less:Impairment of capital assets --0--0--0--0------17.29M--0--0--17.29M----
Other non- operating income (expenses) 123.39%51K92.89%-18K170.27%26K-115.09%-8K168.42%51K-174.91%-218K8.99%-253K-110.00%-37K-76.96%53K161.29%19K
Income before tax 31.61%-79.75M-133.15%-41.48M38.34%-18.27M105.66%2.13M29.89%-22.14M2.21%-116.61M7.36%-17.79M-7.42%-29.62M24.00%-37.62M-37.52%-31.58M
Income tax -77.38%1.38M-104.72%-270K491.15%1.34M-373.53%-186K561.33%496K1,171.13%6.08M221.03%5.72M-79.64%226K-95.89%68K-94.60%75K
Net income 33.88%-81.13M-75.31%-41.21M34.33%-19.6M106.15%2.32M28.49%-22.64M-3.39%-122.7M-62.31%-23.51M-4.05%-29.85M26.33%-37.69M-29.98%-31.65M
Net income continuous Operations 33.88%-81.13M-75.31%-41.21M34.33%-19.6M106.15%2.32M28.49%-22.64M-3.39%-122.7M-62.31%-23.51M-4.05%-29.85M26.33%-37.69M-29.98%-31.65M
Minority interest income
Net income attributable to the parent company 33.88%-81.13M-75.31%-41.21M34.33%-19.6M106.15%2.32M28.49%-22.64M-3.39%-122.7M-62.31%-23.51M-4.05%-29.85M26.33%-37.69M-29.98%-31.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 33.88%-81.13M-75.31%-41.21M34.33%-19.6M106.15%2.32M28.49%-22.64M-3.39%-122.7M-62.31%-23.51M-4.05%-29.85M26.33%-37.69M-29.98%-31.65M
Basic earnings per share 33.33%-1.08-77.42%-0.5533.33%-0.26106.12%0.0328.57%-0.35.81%-1.62-63.16%-0.314.88%-0.3935.53%-0.49-16.67%-0.42
Diluted earnings per share 33.33%-1.08-77.42%-0.5533.33%-0.26106.12%0.0328.57%-0.35.81%-1.62-63.16%-0.314.88%-0.3935.53%-0.49-13.51%-0.42
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -